Clinical Trial Detail

NCT ID NCT03450018
Title A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (SLC-0111-17-01)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

pancreatic ductal adenocarcinoma

Therapies

Gemcitabine + SLC-0111

Age Groups: adult senior

No variant requirements are available.